• Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
    • Kautz-Freimuth S, Redaèlli M, Isselhard A, Shukri A, Vodermaier A, Rhiem K, Schmutzler R, Stock S.
    • Trials. 2022 Feb 16;23(1):157. doi: 10.1186/s13063-022-06081-7.